Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Charles Simonton , Craig Thompson , Jason R Wollmuth , et al Added: 3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary… View more
Author(s): Marvin J Slepian Added: 3 years ago
Heart failure remains the final common pathway of all forms of heart disease. Currently, more than 20 million patients suffer with heart failure in the US and Europe combined.1 Over the past two decades, advances in medical therapeutics have made inroads in reducing mortality associated with early- and mid-stage heart failure. Unfortunately, once patients progress to advanced heart failure, i.e… View more
Job title: Interventional Cardiologist
Dr Rodrigo Bagur is anInterventional Cardiologist at theLondon Health Sciences Centre, in London, Ontario, Canada. His clinical interests are cardiovascular interventions including transradial and structural intervention. Dr Bagur's research revolves around clinical epidemiology, chronic disease and multimorbidity. Dr Bagur attended the National University of Cordoba in Cordoba, Argentina,… View more
Job title: MD
Professor Gerald Werner has been Director of Cardiology and Intensive Care at the Darmstadt Clinic, a teaching hospital of the University of Frankfurt, since 2005. This post followed a period of 7 years as Professor of Cardiology at the Friedrich Schiller University Jena, where he was Deputy Director of the Cardiology Department and Head of the catheter laboratory. Prior to this, Professor Werner… View more
Author(s): Michael M McNally , Michael C Stoner Added: 3 years ago
Treatment for blood clots and their life-threatening sequelae has expanded significantly over the past 50 years. Thrombolytic therapy has gained widespread acceptance and use. Advances in technology have led to experiments with catheter-directed thrombolytic therapy in combination with other physical modality delivery systems, such as ultrasound, to improve the efficacy of thrombolytic therapy… View more
Author(s): Rafael Romaguera Added: 2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx… View more
Author(s): Charles H Hennekens , Danielle Hollar , Arthur S Agatston Added: 3 years ago
While the proximate cause of virtually all acute cardiovascular disease (CVD) syndromes is thrombosis, the principal underlying cause is atherosclerosis. With respect to aspirin, in basic research this drug irrepressibly acetylates the active site of cyclo-oxygenase in platelets which inhibits thromboxane A2, a powerful promoter of aggregation. In randomized trials of secondary prevention and… View more
Author(s): Jennifer Franke , Horst Sievert Added: 3 years ago
After having performed angioplasty in coronary and peripheral vascular disease with excellent results, carotid angioplasty was thought to be an opportunity to simplify the treatment of carotid stenosis. Up until then there was no apparent reason to protect patients against distal embolisation. With the development of carotid angioplasty and stenting, prevention of distal embolisation of… View more